LY3143921
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY3143921, covering 2024-12-17 to 2024-12-17. Get the full timeline:
Most recent: Clinical Trial Update: A CR-UK Phase I Trial of LY3143921 [Phase 1]